EcoDrugPlus

Glutamate Receptor Ionotropic, Nmda 1-Like

Ensembl ID : ENSCING00000009674
Gene Symbol: LOC100184418
3 Cross references
182 Possible Orthologues:

Glycogen Synthase Kinase Alpha/beta

Ensembl ID : ENSCING00000001821
Gene Symbol: GSK
4 Cross references
504 Possible Orthologues:

Histone Deacetylase 1-Like

Ensembl ID : ENSCING00000002649
Gene Symbol: LOC100186761
4 Cross references
211 Possible Orthologues:

Histone Deacetylase 11

Ensembl ID : ENSCING00000016005
Gene Symbol: LOC100180537
4 Cross references
209 Possible Orthologues:

Isocitrate Dehydrogenase [Nadp] Cytoplasmic

Ensembl ID : ENSCING00000018343
Gene Symbol: LOC100184016
4 Cross references
235 Possible Orthologues:

Leukotriene A-4 Hydrolase

Ensembl ID : ENSCING00000009291
Gene Symbol: LOC100176354
4 Cross references
207 Possible Orthologues:

Lysine-Specific Histone Demethylase 1a

Ensembl ID : ENSCING00000006580
Gene Symbol: LOC100187100
4 Cross references
214 Possible Orthologues:

Macrophage Migration Inhibitory Factor-Like

Ensembl ID : ENSCING00000021369
Gene Symbol: LOC100183461
4 Cross references
234 Possible Orthologues:

Macrophage Migration Inhibitory Factor-Like

Ensembl ID : ENSCING00000021423
Gene Symbol: LOC100175627
4 Cross references
233 Possible Orthologues:

Mitogen-Activated Protein Kinase

Ensembl ID : ENSCING00000007067
Gene Symbol: ERK1/2
4 Cross references
214 Possible Orthologues:

Mitogen-Activated Protein Kinase Kinase

Ensembl ID : ENSCING00000004105
Gene Symbol: MAPKK1/2
4 Cross references
485 Possible Orthologues:

Mucosa-Associated Lymphoid Tissue Lymphoma Translocation Protein 1-Like

Ensembl ID : ENSCING00000021118
Gene Symbol: LOC100185957
4 Cross references
376 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).